ATR vs BNTX
AptarGroup vs BioNTech SE — AI-powered side-by-side comparison
| Metric | ATR | BNTX |
|---|
| AI Score |
69
|
66
|
| Price |
$134.62
|
$92.76
|
| P/E Ratio |
24.06×
|
-11.76×
|
| ROE |
14.7%
|
-5.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
28.3%
|
68.9%
|
| Debt / Equity |
0.54×
|
0.02×
|
| Dividend Yield |
1.4%
|
0.0%
|
| RSI (14) |
48.2
|
54.0
|
| Beta |
0.382
|
1.278
|
| Expected Upside |
+1.6%
|
—
|
AI Committee View
Current Innellis committee reasoning for ATR versus BNTX.
ATR leads by 3 points.
ATR scores 69/100 (Buy) versus BNTX at 66/100 (Buy).
ATR Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
BNTX Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro